A Single Dose Study of Debio 1450 in Healthy Subjects

NCT02162199 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Debio 1450
DRUG: Placebo

Sponsor

Debiopharm International SA